Between 29 April and 23 June 2023, highly pathogenic avian influenza (HPAI) A(H5N1) virus (clade 2.3.4.4b) outbreaks were reported in domestic (98) and wild (634) birds across 25 countries in Europe.
Antiviral drugs and monoclonal antibodies (mAbs), administered either separately or as combination therapy 'cocktails’, have provided a valuable tool for fighting COVID-19. Surveillance data, coupled with data on antiviral treatment susceptibility, can guide clinical decisions on selecting the best therapy for the patient.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 July 2023 and includes updates on avian influenza in domestic cats, pride celebrations, diphtheria, COVID-19, West Nile virus, mass gatherings, measles, Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, and Ralstonia mannitolilytica in dialysis patients.